Showing results (11-20 of 183) with videos related to
Sort By:
Pageof 19
Current Treatment Options in Oncology|February 26, 2020
Recent Advances in the Management of Acute Lymphoblastic LeukaemiaKatharine A Hodby, David I MarksExpert Review of Anti-Infective Therapy|March 25, 2017
Voriconazole for prophylaxis of invasive fungal infections after allogeneic hematopoietic stem cell transplantationDavid I Marks, Qifa Liu, Monica SlavinHematology/Oncology Clinics of North America|December 3, 2014
Allogeneic hematopoietic cell transplantation in adult patients with acute lymphoblastic leukemiaDavid I Marks, Laura Alonso, Rohini RadiaCurrent Hematologic Malignancy Reports|April 6, 2012
Recent developments in the management of T-cell precursor acute lymphoblastic leukemia/lymphomaAdele K Fielding, Lalita Banerjee, David I MarksHistopathology|November 20, 2020
The diagnostic and clinical significance of granulomas in gastrointestinal biopsies from haematopoietic transplant patientsNewton A C S Wong, David I MarksLeukemia & Lymphoma|December 17, 2002
Thrombotic thrombocytopenic purpura following stem cell transplantationSarah L Allford, Jennifer M Bird, David I MarksLeukemia Research Reports|December 22, 2017
Alemtuzumab-based therapy for Secondary Malignant Histiocytosis arising from Pre-B-ALLMuhammad Bilal Abid, Karan Wadera, Jenny M Bird, et al.British Journal of Haematology|February 3, 2005
Less than half of patients aged 65 years or under with myeloma proceed to transplantation: results of a two region population-based surveyT C M Morris, Mark Velangi, Graham Jackson, et al.Practical Neurology|June 1, 2018
Advising patients seeking stem cell interventions for multiple sclerosisBeatrice von Wunster, Steven Bailey, Alastair Wilkins, et al.Cancer|March 7, 2018
Patient-reported outcomes from a phase 3 randomized controlled trial of inotuzumab ozogamicin versus standard therapy for relapsed/refractory acute lymphoblastic leukemiaHagop M Kantarjian, Yun Su, Elias J Jabbour, et al.Pageof 19